The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
In the recent years, Johnson & Johnson (JnJ) has changed and updated their validation approach to fully embrace a digital and risk-based approach to validation. As part of an ongoing project, together with Deloitte, these principles are fully embedded and included during the implementation of a new SAP S/4 HANA platform to further support the business of JnJ. During the presentation we will present JnJ's approach to risk based validation followed by a more in depth look at how these principles are used by Deloitte together with JnJ during the SAP S/4 HANA platform and how this ties back in into the CSA principles as documented in the recent draft guidance from FDA by fully utilizing tools (agile development tools, testing tools, dedicated validation tools) to make the shift from document based validation to record based validation.
Speaker(s):
Nele
Ooms,
Head Europe and Africa Technology Quality & Compliance,
Johnson & Johnson
Bernard
Siebens,
Senior Manager, Quality & Compliance,
Deloitte Belgium
You must be logged in and own this session in order to
post comments.